These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 750374)

  • 1. Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.
    Becker EL; Koza EP; Sigman M
    Immunology; 1978 Aug; 35(2):373-80. PubMed ID: 750374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement for esterase activation in the anti-immunoglobulin-triggered movement of B lymphocytes.
    Becker EL; Unanue ER
    J Immunol; 1976 Jul; 117(1):27-32. PubMed ID: 1084365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE mediated triggering of rat basophil leukemia cells: lack of evidence for serine esterase activation.
    Taurog JD; Fewtrell C; Becker EL
    J Immunol; 1979 Jun; 122(6):2150-3. PubMed ID: 448121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotactic factors induced movement of calcium and sodium across rabbit neutrophil membranes: effect of densensitization to cytochalasin B.
    Naccache PH; Showell HJ; Becker EL; Sha'afi RI
    J Cell Physiol; 1979 Aug; 100(2):239-50. PubMed ID: 511943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diisopropylfluorophosphate-evoked inhibition of anaphylactic histamine release from human skin: decrease of the inhibition by storing the skin specimens.
    Yamamoto S; Greaves MW
    Acta Derm Venereol; 1979; 59(2):121-4. PubMed ID: 84487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes.
    Goldstein IM; Hoffstein ST; Weissmann G
    J Immunol; 1975 Sep; 115(3):665-70. PubMed ID: 1151072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of phagocytosis by and lysosomal enzyme secretion from guinea-pig neutrophils: effect of nonsteroid anti-inflammatory agents and prostaglindins.
    Smith RJ
    J Pharmacol Exp Ther; 1977 Mar; 200(3):647-57. PubMed ID: 850132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.
    Becker EL; Showell HJ
    J Immunol; 1974 Jun; 112(6):2055-62. PubMed ID: 4825785
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of an activatable esterase in immune-dependent phagocytosis by human neutrophils.
    Musson RA; Becker EL
    J Immunol; 1977 Apr; 118(4):1354-65. PubMed ID: 850067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.
    Becker EL; Ward PA
    J Exp Med; 1969 Mar; 129(3):569-84. PubMed ID: 5812915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    Ward PA; Becker EL
    J Exp Med; 1968 Apr; 127(4):693-709. PubMed ID: 5642465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzyme secretion and volume contraction induced in neutrophils by cytochalasin B, chemotactic factor and A23187.
    Koza EP; Wright TE; Becker EL
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):476-9. PubMed ID: 1098054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
    Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
    J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.
    Mandell BF; Spilberg I; Lichtman J
    J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urate crystal-induced chemotactic factor: isolation and partial characterization.
    Spilbert I; Gallacher A; Mehta JM; Mandell B
    J Clin Invest; 1976 Oct; 58(4):815-9. PubMed ID: 965488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants.
    Verghese MW; Charles L; Jakoi L; Dillon SB; Snyderman R
    J Immunol; 1987 Jun; 138(12):4374-80. PubMed ID: 3108387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.
    Spilberg I; Gallacher A; Mendell B
    J Lab Clin Med; 1975 Apr; 85(4):631-6. PubMed ID: 1120930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.